Delivery Order SPE2DB22D3004-SPE2DB24FPE00

Award Date 2/1/24
Potential Completion Date 2/2/24
Potential Value $7.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $6,863.94 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 45 MG TABLET UU 28S. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a $17,804.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4565295301 - RINVOQ ER 30 MG TABLET UU 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which allows DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $7,275.16, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,492.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 15 MG TABLET pharmaceutical products. The contract has a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) the company holds with DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,983.60 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4564110483 RINVOQ ER 30 MG TABLET UU 30S. This order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $6,942.03 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 MG TABLET UU 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has no set-aside designation...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564109799 RINVOQ ER 30 MG TABLET UU 30S. The contract has a ceiling value of $3,999.43 and a period of performance through March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has been awarded multiple federal contracts by DLA to provide pharmaceutical products and medical supplies in...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,640.94 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RINVOQ ER 15 MG TABLET, a specialty medication, to support government healthcare programs. This award is part of AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a wide range of...
The Defense Logistics Agency (DLA) awarded a $69,691.00 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of RINVOQ ER 45 MG TABLET UU 28S. This is a delivery order issued under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025 for the provision of a comprehensive range...
The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) awarded a $14,048.42 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4566803438 - RINVOQ ER 15 MG TABLET UU 30S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for supplying a range of pharmaceutical...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FPE00
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,074.07 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of RINVOQ ER 30 MG TABLET UU 30S. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA Troop Support Medical, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. This specific delivery order has a completion date of February 2, 2024. No set-aside designation was used for this contract.

Generated 5/2/24, 10:40 AM